Clinical trial Recruiting at 1 site Observational Ages 18 to 90

Understanding the coronary circulation in Takotsubo syndrome

Official title: Characterisation of the Biochemical Profile and Physiology of the Coronary Circulation in Takotsubo Syndrome

Run by A.O.U. Città della Salute e della Scienza · NCT06669962 · Data updated 2026-11-12

This study looks at how blood flow in the tiny heart vessels works in people with Takotsubo syndrome to see how it affects their symptoms and recovery.

Quick facts

Study typeObservational
Ages18 Years to 90 Years
SexAll
Enrollment50 (estimated)
SponsorA.O.U. Città della Salute e della Scienza
Academic / other
Locations1 site (Turin, Turin)
StatusRecruiting
StartedJuly 10, 2024
Main results expectedJune 27, 2026
Study endsJune 27, 2027
Registry record updatedNovember 1, 2024
Trial IDNCT06669962 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older diagnosed with Takotsubo syndrome.

Probably not a fit

Patients under 18 years old or those who refuse to provide informed consent will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study includes consenting patients over 18 years old diagnosed with Takotsubo syndrome to evaluate the incidence of coronary microcirculation dysfunction. It aims to correlate this dysfunction with clinical presentations and prognosis. Secondary endpoints include assessing in-hospital mortality, cardiogenic shock prevalence, and the relationship between biomarkers and microvascular dysfunction. The study will follow patients for one month and one year after enrollment, which lasts for two years.

Why it matters

Potential benefit: If successful, this study could improve the understanding and management of Takotsubo syndrome, potentially leading to better patient outcomes.

How similar studies have gone: While there have been studies on Takotsubo syndrome, this specific focus on coronary microcirculation dysfunction is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥ 18 years;
* Diagnosis of Takotsubo syndrome
* Signing of informed consent

Exclusion Criteria:

* Age \<18 years;
* Refusal to sign written informed consent.

Where it's running

  • AOU Città della Salute e della Scienza
    Turin, Turin, Italy
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.